Cargando…

New anti-cancer explorations based on metal ions

Due to the urgent demand for more anti-cancer methods, the new applications of metal ions in cancer have attracted increasing attention. Especially the three kinds of the new mode of cell death, including ferroptosis, calcicoptosis, and cuproptosis, are of great concern. Meanwhile, many metal ions h...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Han, Xu, Qi, Mo, Zhimin, Hu, Xiaoxi, He, Qianyuan, Zhang, Zhanjie, Xu, Zushun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590139/
https://www.ncbi.nlm.nih.gov/pubmed/36274142
http://dx.doi.org/10.1186/s12951-022-01661-w
_version_ 1784814450602147840
author Hu, Han
Xu, Qi
Mo, Zhimin
Hu, Xiaoxi
He, Qianyuan
Zhang, Zhanjie
Xu, Zushun
author_facet Hu, Han
Xu, Qi
Mo, Zhimin
Hu, Xiaoxi
He, Qianyuan
Zhang, Zhanjie
Xu, Zushun
author_sort Hu, Han
collection PubMed
description Due to the urgent demand for more anti-cancer methods, the new applications of metal ions in cancer have attracted increasing attention. Especially the three kinds of the new mode of cell death, including ferroptosis, calcicoptosis, and cuproptosis, are of great concern. Meanwhile, many metal ions have been found to induce cell death through different approaches, such as interfering with osmotic pressure, triggering biocatalysis, activating immune pathways, and generating the prooxidant effect. Therefore, varieties of new strategies based on the above approaches have been studied and applied for anti-cancer applications. Moreover, many contrast agents based on metal ions have gradually become the core components of the bioimaging technologies, such as MRI, CT, and fluorescence imaging, which exhibit guiding significance for cancer diagnosis. Besides, the new nano-theranostic platforms based on metal ions have experimentally shown efficient response to endogenous and exogenous stimuli, which realizes simultaneous cancer therapy and diagnosis through a more controlled nano-system. However, most metal-based agents have still been in the early stages, and controlled clinical trials are necessary to confirm or not the current expectations. This article will focus on these new explorations based on metal ions, hoping to provide some theoretical support for more anti-cancer ideas.
format Online
Article
Text
id pubmed-9590139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95901392022-10-25 New anti-cancer explorations based on metal ions Hu, Han Xu, Qi Mo, Zhimin Hu, Xiaoxi He, Qianyuan Zhang, Zhanjie Xu, Zushun J Nanobiotechnology Review Due to the urgent demand for more anti-cancer methods, the new applications of metal ions in cancer have attracted increasing attention. Especially the three kinds of the new mode of cell death, including ferroptosis, calcicoptosis, and cuproptosis, are of great concern. Meanwhile, many metal ions have been found to induce cell death through different approaches, such as interfering with osmotic pressure, triggering biocatalysis, activating immune pathways, and generating the prooxidant effect. Therefore, varieties of new strategies based on the above approaches have been studied and applied for anti-cancer applications. Moreover, many contrast agents based on metal ions have gradually become the core components of the bioimaging technologies, such as MRI, CT, and fluorescence imaging, which exhibit guiding significance for cancer diagnosis. Besides, the new nano-theranostic platforms based on metal ions have experimentally shown efficient response to endogenous and exogenous stimuli, which realizes simultaneous cancer therapy and diagnosis through a more controlled nano-system. However, most metal-based agents have still been in the early stages, and controlled clinical trials are necessary to confirm or not the current expectations. This article will focus on these new explorations based on metal ions, hoping to provide some theoretical support for more anti-cancer ideas. BioMed Central 2022-10-23 /pmc/articles/PMC9590139/ /pubmed/36274142 http://dx.doi.org/10.1186/s12951-022-01661-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Hu, Han
Xu, Qi
Mo, Zhimin
Hu, Xiaoxi
He, Qianyuan
Zhang, Zhanjie
Xu, Zushun
New anti-cancer explorations based on metal ions
title New anti-cancer explorations based on metal ions
title_full New anti-cancer explorations based on metal ions
title_fullStr New anti-cancer explorations based on metal ions
title_full_unstemmed New anti-cancer explorations based on metal ions
title_short New anti-cancer explorations based on metal ions
title_sort new anti-cancer explorations based on metal ions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590139/
https://www.ncbi.nlm.nih.gov/pubmed/36274142
http://dx.doi.org/10.1186/s12951-022-01661-w
work_keys_str_mv AT huhan newanticancerexplorationsbasedonmetalions
AT xuqi newanticancerexplorationsbasedonmetalions
AT mozhimin newanticancerexplorationsbasedonmetalions
AT huxiaoxi newanticancerexplorationsbasedonmetalions
AT heqianyuan newanticancerexplorationsbasedonmetalions
AT zhangzhanjie newanticancerexplorationsbasedonmetalions
AT xuzushun newanticancerexplorationsbasedonmetalions